Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-06-02 @ 5:20 PM
Study NCT ID:
NCT03595657
Status:
COMPLETED
Last Update Posted:
2024-06-18
First Post:
2018-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)
Sponsor:
CStone Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-12
First Submit QC Date:
None
Study First Post Date:
2018-07-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-14
Results First Submit QC Date:
None
Results First Post Date:
2024-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-22
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL